PRAX 8-K 2026-11-09

Praxis Precision Medicines, Inc. (PRAX) 8-K dated 2026-11-09 — accession 0001689548-26-000086.

Praxis Precision Medicines, Inc. (PRAX) is a biotechnology company listed on US.

PRAX: Praxis Precision Medicines Provides Corporate Update and Reports Third…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PRAX revenue for 2025-12-31 was $0. Net income was -$303.3M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. PRAX currently screens at market cap $7.38B.

Not investment advice. The PRAX SEC hub lists recent forms. The stock page is the research view.